Ischemic stroke risk and mortality were highest in diabetes patients treated with insulin and lowest in patients not receiving active pharmacological treatment compared to the general population (Fig. 3 and Additional file 1: Table S4). The gene discussed is INS; the disease is ischemic stroke.